{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:52:19Z","timestamp":1772041939196,"version":"3.50.1"},"reference-count":30,"publisher":"Walter de Gruyter GmbH","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jaoa.2019.132_s_001\">\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>In 2015, Solano County's Medi-Cal insurer implemented a new policy to taper patients using high-dose opioids (\u2265120-mg morphine equivalent dose) to a safer level to follow best practices to address the opioid epidemic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2019.132_s_002\">\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the effect of the 2015 Solano County Medi-Cal prescribing policy, gain insight into the patient experience of undergoing opioid tapering, and generate hypotheses for further study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2019.132_s_003\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using a case series approach, researchers completed medical record reviews of affiliated clinical records, Solano County Vital Statistics, and California's prescription monitoring program in 2018. After exclusions, eligible patients were asked to participate in a comprehensive qualitative interview.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2019.132_s_004\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Medical record reviews of 38 patients found the majority were not using opioids using them at a morphine equivalent dose of 90 mg or less. The reviews also found that mental illness and obesity prevalence were higher than Solano county baseline levels. Furthermore, naloxone was not prescribed to any of the 38 patients. Researchers reached 15 of the 38 patients by phone, and ultimately 6 completed the interview process. Themes and emergent concepts from interviews identified a lack of empathetic connection with health care professionals, poor understanding of overdose risks, persistent pain, and confirmed naloxone underuse.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jaoa.2019.132_s_005\">\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Safer prescribing policies may take multiple years to fully implement and need to be employed across the jurisdiction to minimize doctor-shopping and adverse effects on patients with chronic pain. Approaching pain management through the social-ecological model can address potential root causes of addiction and establish a framework for doctors to provide compassionate care, community leadership, and advocacy for these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.7556\/jaoa.2019.132","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T19:45:22Z","timestamp":1575315922000},"page":"793-801","source":"Crossref","is-referenced-by-count":5,"title":["Adapting the Social-Ecological Framework for Chronic Pain Management and Successful Opioid Tapering"],"prefix":"10.1515","volume":"119","author":[{"given":"Christine A.","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari J.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Modrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela T.","family":"Matyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay H.","family":"Shubrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,12,1]]},"reference":[{"key":"2022022617384071211_j_jaoa.2019.132_ref_001","volume-title":". Accessed April 10, 2018","year":"2018"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_002","volume-title":"Prescription Nation: Addressing America's Drug Epidemic. Itasca","author":"Council","year":"2018"},{"issue":"15","key":"2022022617384071211_j_jaoa.2019.132_ref_003","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"Chou R","volume":"315","author":"Dowell","year":"2016","journal-title":"CDC guideline for prescribing opioids for chronic pain--United States"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_004","volume-title":"Case Studies: Three California Health Plans Take Action Against Opioid Overuse. Oakland","year":"2016"},{"issue":"4","key":"2022022617384071211_j_jaoa.2019.132_ref_005","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/ajim.21998","article-title":"Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline","volume":"55","author":"Franklin","year":"2012","journal-title":"Am J Ind Med"},{"issue":"6","key":"2022022617384071211_j_jaoa.2019.132_ref_006","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"suppl 3","key":"2022022617384071211_j_jaoa.2019.132_ref_007","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2106\/JBJS.H.01573","article-title":"How to design a good case series","volume":"91","author":"Kooistra","year":"2009","journal-title":"J Bone Joint Surg Am"},{"issue":"4","key":"2022022617384071211_j_jaoa.2019.132_ref_008","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/0003-4819-134-4-200102200-00017","article-title":"In defense of case reports and case series","volume":"134","author":"Vandenbroucke","year":"2001","journal-title":"Ann Intern Med"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_009","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511557842","volume-title":"Qualitative Analysis for Social Scientist","author":"Strauss","year":"1987"},{"issue":"7226","key":"2022022617384071211_j_jaoa.2019.132_ref_010","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/bmj.320.7226.50","article-title":"Assessing quality in qualitative research","volume":"320","author":"Mays","year":"2000","journal-title":"BMJ"},{"issue":"7227","key":"2022022617384071211_j_jaoa.2019.132_ref_011","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/bmj.320.7227.114","article-title":"Analysing qualitative data.","volume":"320","author":"Pope","year":"2000","journal-title":"BMJ."},{"key":"2022022617384071211_j_jaoa.2019.132_ref_012","volume-title":"Strengths and Limitations of CMS Administrative Data in Research. Minneapolis","year":"2018"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_013","volume-title":"Davies MC. Associations of Nonmedical Pain Reliever use and Initiation of Heroin Use in the United States. Rockville","author":"Muhuri","year":"2013"},{"issue":"2","key":"2022022617384071211_j_jaoa.2019.132_ref_014","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"issue":"1-2","key":"2022022617384071211_j_jaoa.2019.132_ref_015","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2013.01.007","article-title":"Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010","volume":"132","author":"Jones","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_016","article-title":"The perfect storm: opioid risks and \u201cthe holy trinity.","volume-title":"Pharmacy Times","author":"Fudin","year":"2014"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_017","volume-title":"Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research","year":"2011"},{"issue":"12","key":"2022022617384071211_j_jaoa.2019.132_ref_018","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1111\/j.1526-4637.2010.00960.x","article-title":"\u201cThey don't want anything to do with you\u201d: patient views of primary care management of chronic pain","volume":"11","author":"Upshur","year":"2010","journal-title":"Pain Med"},{"issue":"10","key":"2022022617384071211_j_jaoa.2019.132_ref_019","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1093\/pm\/pnw078","article-title":"Patients\u2019 perspectives on tapering of chronic opioid therapy: a qualitative study","volume":"17","author":"Frank","year":"2016","journal-title":"Pain Med"},{"issue":"4","key":"2022022617384071211_j_jaoa.2019.132_ref_020","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0749-3797(98)00017-8","article-title":"Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the adverse childhood experiences (ACE) study","volume":"14","author":"Felitti","year":"1998","journal-title":"Am J Prev Med"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_021","year":"2017"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_022","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2016.09.021","article-title":"The relationships of childhood trauma and adulthood prescription pain reliever misuse and injection drug use","volume":"169","author":"Quinn","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2022022617384071211_j_jaoa.2019.132_ref_023","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/10550880802545101","article-title":"The prevalence of childhood trauma among those seeking buprenorphine treatment","volume":"28","author":"Sansone","year":"2009","journal-title":"J Addict Dis"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_024","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.drugalcdep.2017.07.007","article-title":"Adverse childhood experience effects on opioid use initiation, injection drug use, and overdose among persons with opioid use disorder","volume":"179","author":"Stein","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_025","volume-title":"Shasta County Adverse Childhood Experiences Efforts","author":"Deckert","year":"2018"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_026","first-page":"23","article-title":"Examining adverse childhood events as a root cause of the opioid epidemic and the urgent need for trauma-informed care","author":"Blodgett","year":"2018","journal-title":"Presented at: American College of Preventive Medicine Annual Meeting. May"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_027","article-title":"Ecological models of human development.","volume-title":"International Encyclopedia of Education","author":"Bronfenbrenner","year":"1977","edition":"2nd"},{"issue":"2","key":"2022022617384071211_j_jaoa.2019.132_ref_028","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.chc.2014.01.002","article-title":"The biological effects of childhood trauma","volume":"23","author":"De Bellis","year":"2014","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"suppl 1","key":"2022022617384071211_j_jaoa.2019.132_ref_029","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1526-4637.2009.00596.x","article-title":"Opioid metabolism and effects of cytochrome P450","volume":"10","author":"Holmquist","year":"2009","journal-title":"Pain Med"},{"key":"2022022617384071211_j_jaoa.2019.132_ref_030","author":"mandatory use","year":"2018"}],"container-title":["Journal of Osteopathic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.132\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T17:40:04Z","timestamp":1645897204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.7556\/jaoa.2019.132\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,1]]},"published-print":{"date-parts":[[2019,12,1]]}},"alternative-id":["10.7556\/jaoa.2019.132"],"URL":"https:\/\/doi.org\/10.7556\/jaoa.2019.132","relation":{},"ISSN":["2702-3648"],"issn-type":[{"value":"2702-3648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,1]]}}}